NCT05558033 is a NA clinical trial of Plyometric Exercise in Muscle Architecture, sponsored by Hacettepe University.

Who is sponsoring NCT05558033?

NCT05558033 is sponsored by Hacettepe University.

What drugs are being tested in NCT05558033?

Interventions in NCT05558033: Plyometric Exercise, Football Training.

What condition does NCT05558033 study?

NCT05558033 studies Muscle Architecture.

Is NCT05558033 still recruiting?

NCT05558033 is currently status unknown. Last updated 29 November 2022.

Last reviewed 2022-11-29 · How we verify

NCT05558033

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Motor Imagery and Muscle Architecture

Status unknown NA Last updated 29 November 2022

What this trial tests

NA trial testing Plyometric Exercise in Muscle Architecture in 40 participants. Status unknown.

Timeline

21 November 2022

Primary endpoint
15 March 2023

15 June 2023

Quick facts

Lead sponsor	Hacettepe University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	40
Start date	21 November 2022
Primary completion	15 March 2023
Estimated completion	15 June 2023
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

Plyometric Exercise
Football Training

Conditions studied

Muscle Architecture — all drugs for Muscle Architecture →

Sponsor

Hacettepe University

Who can join

Adults 12 to 19, male only, with Muscle Architecture. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to examine the effects of plyometric training on biceps femoris longus (BFl) and vastus lateralis (VL) muscle architecture in healthy football players. Individuals will be randomly placed into training and control groups. Measurements of muscle architecture will be taken bilaterally from BFl and VL muscles by means of an ultrasound device. Functional performance will be evaluated with the single leg jump test. Following the initial evaluations, individuals in the training group will receive plyometric training. Evaluations of muscle architecture and functional performance will be taken again from the individuals in the training and control groups at the end of the 4th and 8th weeks. The received ultrasound images will be calculated through the MicroDicom software. In-group and between-group comparisons will be analyzed using the Statistical Package for the Social Sciences program and appropriate tests.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Plyometric Exercise

Trials testing the same drug.

NCT06688279 — Effects of Plyometric Exercises in Female Fast Bowlers · NA · recruiting
NCT06980246 — Utility of Upper-Extremity Plyometrics in Children With Unilateral Cerebral Palsy · NA · completed
NCT04690127 — Muscle Architecture and Anterior Cruciate Ligament · NA · unknown

Other recruiting trials for Muscle Architecture

Currently open trials in the same condition.

NCT07367243 — Percussive Massage Therapy and Muscle Architecture · NA · recruiting

Other Hacettepe University trials

Trials by the same sponsor.

NCT07522060 — Early Functional Response as a Predictor of Clinical Outcomes in Hand Rehabilitation: A Prospective Feasibility Study Us · not yet recruiting
NCT07390162 — The Effect of Changes in the Frequency of Endotracheal Tube Repositioning in Intensive Care Units on the Prevention of O · NA · not yet recruiting
NCT07579676 — DEVELOPMENT AND PSYCHOMETRIC EVALUATION OF THE NEUROCOGNITIVE UPPER EXTREMITY TESTS: A RELIABILITY AND VALIDITY STUDY · not yet recruiting
NCT07524842 — Clinical Performance of Three Different Restorative Materials · NA · not yet recruiting
NCT07439861 — The Effect of Cognitive Dual-Task on Athletic Performance Parameters in Volleyball Players With and Without Chronic Ankl · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05558033 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hacettepe University
Last refreshed: 29 November 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05558033.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing